University of Texas Southwestern Medical Center

October ended and November began with the announcement of three new venture capital and equity funds with more than $1.3bn for health care, life science and biopharmaceutical investments. Revelation P

Atavistik Bio revealed a $60m series A round on 24 August that it will use to ramp up its discovery of novel therapeutics with distinct allosteric control mechanisms for the treatment of metabolic di

BridgeBio Pharma, Inc. employs a business model of acquiring rights to or partnering with academic and institutional research in monogenic diseases and genetic cancer indications, often forming singl

Who: Amgen/Rodeo Therapeutics What: Amgen agreed to buy privately held Rodeo for $55m and potential earnouts. Why: In its second M&A deal of the year, Amgen acquired a company focused on therapie